JP2001512456A5 - - Google Patents

Download PDF

Info

Publication number
JP2001512456A5
JP2001512456A5 JP1998535780A JP53578098A JP2001512456A5 JP 2001512456 A5 JP2001512456 A5 JP 2001512456A5 JP 1998535780 A JP1998535780 A JP 1998535780A JP 53578098 A JP53578098 A JP 53578098A JP 2001512456 A5 JP2001512456 A5 JP 2001512456A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998535780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001512456A (ja
Filing date
Publication date
Priority claimed from US08/800,009 external-priority patent/US5864023A/en
Application filed filed Critical
Publication of JP2001512456A publication Critical patent/JP2001512456A/ja
Publication of JP2001512456A5 publication Critical patent/JP2001512456A5/ja
Ceased legal-status Critical Current

Links

JP53578098A 1997-02-13 1998-02-03 3’−n−オキシド,3’−n−ジメチルアミン,9−オキシムエリスロマイシンa誘導体 Ceased JP2001512456A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/800,009 1997-02-13
US08/800,009 US5864023A (en) 1997-02-13 1997-02-13 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
PCT/US1998/001929 WO1998035976A1 (en) 1997-02-13 1998-02-03 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives

Publications (2)

Publication Number Publication Date
JP2001512456A JP2001512456A (ja) 2001-08-21
JP2001512456A5 true JP2001512456A5 (enExample) 2005-10-06

Family

ID=25177295

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53578098A Ceased JP2001512456A (ja) 1997-02-13 1998-02-03 3’−n−オキシド,3’−n−ジメチルアミン,9−オキシムエリスロマイシンa誘導体

Country Status (25)

Country Link
US (1) US5864023A (enExample)
EP (1) EP0966477B1 (enExample)
JP (1) JP2001512456A (enExample)
KR (1) KR100561326B1 (enExample)
CN (1) CN1326865C (enExample)
AR (1) AR012032A1 (enExample)
AT (1) ATE252108T1 (enExample)
AU (1) AU725274B2 (enExample)
BG (1) BG64099B1 (enExample)
BR (1) BR9807349A (enExample)
CA (1) CA2279932C (enExample)
CZ (1) CZ294481B6 (enExample)
DE (1) DE69818977T2 (enExample)
DK (1) DK0966477T3 (enExample)
ES (1) ES2212266T3 (enExample)
HU (1) HUP0001330A3 (enExample)
IL (1) IL130697A0 (enExample)
NO (1) NO993876L (enExample)
NZ (1) NZ336482A (enExample)
PL (1) PL187357B1 (enExample)
PT (1) PT966477E (enExample)
SK (1) SK284157B6 (enExample)
TR (1) TR199901874T2 (enExample)
WO (1) WO1998035976A1 (enExample)
ZA (1) ZA98986B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
CN1666991A (zh) 1999-12-16 2005-09-14 特瓦制药工业有限公司 克拉霉素多晶型物的制备方法和新的多晶型物ⅳ
CN1450903A (zh) 2000-01-11 2003-10-22 特瓦制药工业有限公司 克拉霉素多晶型物的制备方法
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
CA2401571A1 (en) * 2000-02-29 2001-09-07 Ilya Avrutov Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
DE60122791T2 (de) * 2000-03-15 2007-10-04 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von Clarythromycin mit nicht pharmazeutischer Qualität
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 a의 제조방법
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
WO2005009368A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648415A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023184A2 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
EP1771158A4 (en) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSE DISTRIBUTION
US7694523B2 (en) * 2004-07-19 2010-04-13 Earthrenew, Inc. Control system for gas turbine in material treatment unit
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−n−メチルエリスロマイシン誘導体
EP0254534A3 (en) * 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンaオキシム及びその塩の製造方法

Similar Documents

Publication Publication Date Title
JP2000509635A5 (enExample)
JP2000509637A5 (enExample)
JP2000509912A5 (enExample)
JP2000509942A5 (enExample)
JP2000510751A5 (enExample)
JP2002511905A5 (enExample)
JP2001519126A5 (enExample)
JP2002513417A5 (enExample)
JP2000509587A5 (enExample)
JP2001514830A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2001508794A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2001512456A5 (enExample)
JP2001520515A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2001526535A5 (enExample)
JP2000510247A5 (enExample)
JP2000508836A5 (enExample)
JP2000509520A5 (enExample)